Telik Inc.

3165 Porter Drive
Palo Alto, CA 94304

USA

Phone: (650) 845-7700
Fax: (650) 244-9388
Email: inquiry@telik.com
Web Site: http://www.telik.com/

A. Company Profile

Telik, Inc. (NASDAQ: TELK) is a biotech company working to develop small molecule drugs to treat cancer and other serious diseases for which there is significant demand for new therapies.

B. Products

Product Pipelines

1.      Telcyta

Telcyta (TLK286) is a small molecule activated by glutathione S-transferase P1-1 (GSTP1-1), an enzyme present in higher levels in many human cancers than in normal tissues. Upon activation, an intracellular process known as apoptosis, or progammed cell death, is activated.

2.      Telintra

Telintra (TLK199), a small molecule bone marrow stimulant, is in a Phase 1-2 trial in myelodysplastic syndrome, a form of pre-leukemia.